Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Amortization of Deferred Charges: 2022-2025

Historic Amortization of Deferred Charges for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to $248,000.

  • Gossamer Bio's Amortization of Deferred Charges rose 5.98% to $248,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $972,000, marking a year-over-year decrease of 15.92%. This contributed to the annual value of $1.1 million for FY2024, which is 17.79% down from last year.
  • Latest data reveals that Gossamer Bio reported Amortization of Deferred Charges of $248,000 as of Q3 2025, which was up 1.22% from $245,000 recorded in Q2 2025.
  • Over the past 5 years, Gossamer Bio's Amortization of Deferred Charges peaked at $352,000 during Q1 2023, and registered a low of $234,000 during Q3 2024.
  • Its 3-year average for Amortization of Deferred Charges is $285,545, with a median of $293,000 in 2024.
  • In the last 5 years, Gossamer Bio's Amortization of Deferred Charges grew by 20.55% in 2023 and then fell by 27.55% in 2024.
  • Quarterly analysis of 4 years shows Gossamer Bio's Amortization of Deferred Charges stood at $270,000 in 2022, then rose by 14.07% to $308,000 in 2023, then dropped by 22.73% to $238,000 in 2024, then rose by 5.98% to $248,000 in 2025.
  • Its Amortization of Deferred Charges was $248,000 in Q3 2025, compared to $245,000 in Q2 2025 and $241,000 in Q1 2025.